Silvercrest Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7M | Sell |
|
|||||
|
2025
Q1 | $15.4M | Buy |
|
|||||
|
2024
Q4 | $11M | Buy |
|
|||||
|
2024
Q3 | $14.8M | Buy |
|
|||||
|
2024
Q2 | $17M | Sell |
|
|||||
|
2024
Q1 | $17.2M | Buy |
|
|||||
|
2023
Q4 | $12.7M | Buy |
|
|||||
|
2023
Q3 | $9.58M | Sell |
|
|||||
|
2023
Q2 | $8.98M | Sell |
|
|||||
|
2023
Q1 | $9.53M | Sell |
|
|||||
|
2022
Q4 | $10.3M | Buy |
|
|||||
|
2022
Q3 | $5.95M | Sell |
|
|||||
|
2022
Q2 | $6.92M | Buy |
|
|||||
|
2022
Q1 | $6.16M | Buy |
|
|||||
|
2021
Q4 | $6.19M | Buy |
|
|||||
|
2021
Q3 | $3.27M | Buy |
|
|||||
|
2021
Q2 | $2.22M | Sell |
|
|||||
|
2021
Q1 | $1.8M | Sell |
|
|||||
|
2020
Q4 | $1.92M | Buy |
|
|||||
|
2020
Q3 | $1.82M | Buy |
|
|||||
|
2020
Q2 | $1.65M | Buy |
|
|||||
|
2020
Q1 | $1.47M | Sell |
|
|||||
|
2019
Q4 | $1.42M | Sell |
|
|||||
|
2019
Q3 | $1.27M | Buy |
|
|||||
|
2019
Q2 | $1.25M | Buy |
|
|||||
|
2019
Q1 | $1.26M | Sell |
|
|||||
|
2018
Q4 | $2.48M | Buy |
|
|||||
|
2018
Q3 | $2.53M | Sell |
|
|||||
|
2018
Q2 | $2.98M | Buy |
|
|||||
|
2018
Q1 | $3.12M | Buy |
|
|||||
|
2017
Q4 | $3.27M | Buy |
|
|||||
|
2017
Q3 | $2.85M | Buy |
|
|||||
|
2017
Q2 | $2.53M | Buy |
|
|||||
|
2017
Q1 | $1.82M | Buy |
|
|||||
|
2016
Q4 | $1.88M | Sell |
|
|||||
|
2016
Q3 | $2.56M | Buy |
|
|||||
|
2016
Q2 | $3.19M | Buy |
|
|||||
|
2016
Q1 | $3.21M | Sell |
|
|||||
|
2015
Q4 | $3.6M | Sell |
|
|||||
|
2015
Q3 | $3.47M | Sell |
|
|||||
|
2015
Q2 | $5.58M | Buy |
|
|||||
|
2015
Q1 | $5.14M | Sell |
|
|||||
|
2014
Q4 | $4.74M | Buy |
|
|||||
|
2014
Q3 | $5.31M | Buy |
|
|||||
|
2014
Q2 | $4.97M | Buy |
|
|||||
|
2014
Q1 | $4.87M | Buy |
|
|||||
|
2013
Q4 | $3.89M | Buy |
|
|||||
|
2013
Q3 | $3.1M | Buy |
|
|||||
|
2013
Q2 | $2.6M | Buy |
|